| Literature DB >> 25033391 |
Jaehun Jung1, Hyejin Shin2, Soyoung Bang2, Hyuck Jun Mok3, Chang Suk Suh4, Kwang Pyo Kim3, Hyunjung Jade Lim2.
Abstract
Oocyte freezing confers thermal and chemical stress upon the oolemma and various other intracellular structures due to the formation of ice crystals. The lipid profiles of oocytes and embryos are closely associated with both, the degrees of their membrane fluidity, as well as the degree of chilling and freezing injuries that may occur during cryopreservation. In spite of the importance of lipids in the process of cryopreservation, the phospholipid status in oocytes and embryos before and after freezing has not been investigated. In this study, we employed mass spectrometric analysis to examine if vitrification has an effect on the phospholipid profiles of mouse oocytes. Freshly prepared metaphase II mouse oocytes were vitrified using copper grids and stored in liquid nitrogen for 2 weeks. Fresh and vitrified-warmed oocytes were subjected to phospholipid extraction procedure. Mass spectrometric analyses revealed that multiple species of phospholipids are reduced in vitrified-warmed oocytes. LIFT analyses identified 31 underexpressed and 5 overexpressed phospholipids in vitrified mouse oocytes. The intensities of phosphatidylinositol (PI) {18∶2/16∶0} [M-H]- and phosphatidylglycerol (PG) {14∶0/18∶2} [M-H]- were decreased the most with fold changes of 30.5 and 19.1 in negative ion mode, respectively. Several sphingomyelins (SM) including SM {d38∶3} [M+H]+ and SM {d34∶0} [M+K]+ were decreased significantly in positive ion mode. Overall, the declining trend of multiple phospholipids demonstrates that vitrification has a marked effect on phospholipid profiles of oocytes. These results show that the identified phospholipids can be used as potential biomarkers of oocyte undergoing vitrification and will allow for the development of strategies to preserve phospholipids during oocyte cryopreservation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25033391 PMCID: PMC4102530 DOI: 10.1371/journal.pone.0102620
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Experimental design and BODIPY/CellMask staining of mouse oocytes prior to and after vitrification.
(A) A schematic diagram showing the experimental design and the three experimental groups. Two sets of vitrified-warmed oocytes with matching controls (represented as Set 1 and Set 2 in the diagram) were used. Since phospholipid extraction and subsequent analyses were performed on the day of oocyte preparation, the 2nd control groups were prepared on the day of thawing vitrified oocytes of the previous set. Another set of control oocytes were prepared when extracting phospholipids from vitrified-warmed oocytes of the 2nd set. This was added to ensure the quality of phospholipid extraction and analyses. Mass spectrometric analyses were performed in all groups shown. For statistical analysis, two full sets of data (shown in beige areas) excluding the last set of controls (shown in gray boxes) were included. (B) Fresh MII oocytes, solution-treated oocytes, and vitrified-warmed oocytes (2-week vitrification) were stained with BODIPY 500/510 (10 µg/ml) and CellMask (2.5 µg/ml). Stained oocytes were washed with media and examined under a confocal microscope without fixation. BODIPY and CellMask are shown in green and red, respectively. The experiment was repeated more than three times with different pools of oocytes. Representative images are shown. Red scale bar, 20 µm.
Figure 2Representative mass spectra of lipids obtained from fresh and vitrified mouse oocytes in (A) positive ion mode and in (B) negative ion mode. m/z, mass-to-charge ratio; au, arbitrary unit.
Figure 3Principal component analysis plots for the phospholipid mass spectra.
Fresh oocytes, green dots; 2-week vitrification, red dots.
Figure 4Fragmentation spectra of representative phospholipid species by using the LIFT technique.
(A) m/z 782.6; PC {34∶1} [M+Na]+ in positive ion mode and (B) m/z 861.6; PI {18∶0/18∶2} [M−H]− in negative ion mode. Fragmentation spectra for other phospholipids are shown in Fig. S3.
Figure 5Hierarchical clustering of each sample data set showing differentially expressed phospholipids.
(A) Positive ion mode. (B) Negative ion mode.
Differentially expressed phospholipids between fresh oocytes and vitrified oocytes (2 weeks).
| Underexpressedphospholipids invitrified oocytes | Overexpressedphospholipids invitrified oocytes | ||||||
|
|
|
|
|
|
|
|
|
|
|
| ||||||
| 777.5 | 4.48E-23 | 10.44 | SM {d38∶3} [M+Na]+ | 808.6 | 2.86E-01 | 0.96 | PC {36∶2} [M+Na]+ |
| 743.6 | 1.53E-23 | 9.78 | SM {d34∶0} [M+K]+ | 806.6 | 2.99E-04 | 0.86 | PC {36∶3} [M+Na]+ |
| 815.6 | 1.12E-27 | 3.58 | SM {d42∶1} [M+H]+ | 884.6 | 5.05E-07 | 0.82 | PC {42∶6} [M+Na]+ |
| 550.5 | 4.72E-22 | 3.05 | LPC {20∶1} [M+H]+ | 650.5 | 4.90E-10 | 0.69 | PC {26∶0} [M+H]+ |
| 727.5 | 6.57E-23 | 2.42 | SM {d34∶0} [M+Na]+ | 685.5 | 1.20E-13 | 0.61 | SM {d30∶1} [M+K]+ |
| 795.6 | 1.84E-22 | 2.16 | SM {d38∶2} [M+K]+ | ||||
| 798.6 | 4.16E-10 | 1.88 | PC {34∶1} [M+K]+ | ||||
| 780.6 | 1.33E-14 | 1.66 | PC {36∶5} [M+H]+ | ||||
| 754.6 | 1.29E-13 | 1.65 | PC {34∶4} [M+H]+ | ||||
| 794.6 | 7.21E-15 | 1.63 | PC {p-38∶4} [M+H]+ | ||||
| 826.6 | 1.95E-10 | 1.61 | PC {38∶7} [M+Na]+ | ||||
| 758.6 | 6.28E-09 | 1.48 | PC {34∶2} [M+H]+ | ||||
| 760.6 | 1.25E-06 | 1.42 | PC {34∶1} [M+H]+ | ||||
| 786.6 | 2.33E-05 | 1.35 | PC {36∶2} [M+H]+ | ||||
| 768.6 | 4.45E-07 | 1.25 | PC {p-36∶3} [M+H]+ | ||||
| 756.6 | 3.05E-07 | 1.24 | PC {34∶3} [M+H]+ | ||||
| 732.6 | 0.000019421 | 1.18 | PC {32∶1} [M+H]+ | ||||
| 723.5 | 6.6907E-06 | 1.17 | SM {d34∶2} [M+Na]+ | ||||
| 782.6 | 0.2259 | 1.04 | PC {34∶1} [M+Na]+ | ||||
|
| |||||||
| 833.6 | 5.93E-17 | 30.52 | PI {18∶2/16∶0} [M−H]− | ||||
| 717.6 | 6.68E-11 | 19.17 | PG {14∶0/18∶2} [M−H]− | ||||
| 699.5 | 2.54E-17 | 7.48 | PA {18∶2/18∶0} [M−H]− | ||||
| 883.6 | 3.82E-09 | 4.38 | PI {20∶4/18∶1} [M−H]− | ||||
| 859.6 | 1.32E-08 | 3.42 | PI {18∶2/18∶1} [M−H]− | ||||
| 755.6 | 3.39E-11 | 2.88 | PG {O-16∶0/20∶4} [M−H]− | ||||
| 861.6 | 6.85E-09 | 2.82 | PI {18∶0/18∶2} [M−H]− | ||||
| 885.6 | 3.41E-05 | 1.91 | PI {20∶4/18∶0} [M−H]− | ||||
| 677.7 | 5.27E-03 | 1.60 | PG {p-16∶0/14∶0} [M−H]− | ||||
| 599.3 | 1.59E-05 | 1.50 | LPI {18∶0} [M−H]− | ||||
| 776.6 | 6.22E-04 | 1.29 | PE {p-20∶0/20∶5} [M−H]− | ||||
| 887.6 | 1.41E-01 | 1.18 | PI {20∶3/18∶0} [M−H]− | ||||
*Ratio, Fresh oocytes/2 weeks vitrified oocytes.
*P, p value.
*PC, Phosphatidylcholines.
*SM, Sphingomyelins.
*LPC, Lysophosphatidylcholine.
*PI, Phosphatidylinositol.
*PG, Phosphatidylglycerol.
*LPI, Lysophosphatidylinositol.
*PE, Phosphatidylethanolamine.
Figure 6Relative intensities of differentially expressed phospholipids in fresh and vitrified oocytes measured by MALDI-TOF MS in (A) positive ion mode and in (B) negative ion mode.
Red dots, phospholipid species with fold changes greater than 2 (p<0.01). (C) Phospholipids that are significantly reduced after vitrification and warming. Fold changes greater than 3 are shown (p<0.01).